Key points are not available for this paper at this time.
Peritoneal dialysis-associated peritonitis is the most common type of infection related to this therapy. It is associated with important outcomes such as protein-energy wasting, increased costs secondary to treatment and medical visits, changes in the peritoneal membrane, need for transfer to hemodialysis (temporary or definitive) and, in a low percentage, death. Therefore, the rate of peritonitis is a reflection of the quality of the dialysis units and must be measured. The most recent literature from the ISPD 2022 comments that the annual rate of peritonitis should be no more than 0.4 episodes/patient-year
Vega et al. (Mon,) studied this question.